Literature DB >> 33688995

Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics.

Valentina Garibotto1,2, Marina Boccardi3, Arturo Chiti4,5, Giovanni B Frisoni6,7.   

Abstract

Entities:  

Year:  2021        PMID: 33688995     DOI: 10.1007/s00259-020-05116-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  9 in total

1.  Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.

Authors:  Gil D Rabinovici; Constantine Gatsonis; Charles Apgar; Kiran Chaudhary; Ilana Gareen; Lucy Hanna; James Hendrix; Bruce E Hillner; Cynthia Olson; Orit H Lesman-Segev; Justin Romanoff; Barry A Siegel; Rachel A Whitmer; Maria C Carrillo
Journal:  JAMA       Date:  2019-04-02       Impact factor: 56.272

Review 2.  Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.

Authors:  Giovanni B Frisoni; Marina Boccardi; Frederik Barkhof; Kaj Blennow; Stefano Cappa; Konstantinos Chiotis; Jean-Francois Démonet; Valentina Garibotto; Panteleimon Giannakopoulos; Anton Gietl; Oskar Hansson; Karl Herholz; Clifford R Jack; Flavio Nobili; Agneta Nordberg; Heather M Snyder; Mara Ten Kate; Andrea Varrone; Emiliano Albanese; Stefanie Becker; Patrick Bossuyt; Maria C Carrillo; Chiara Cerami; Bruno Dubois; Valentina Gallo; Ezio Giacobini; Gabriel Gold; Samia Hurst; Anders Lönneborg; Karl-Olof Lovblad; Niklas Mattsson; José-Luis Molinuevo; Andreas U Monsch; Urs Mosimann; Alessandro Padovani; Agnese Picco; Corinna Porteri; Osman Ratib; Laure Saint-Aubert; Charles Scerri; Philip Scheltens; Jonathan M Schott; Ida Sonni; Stefan Teipel; Paolo Vineis; Pieter Jelle Visser; Yutaka Yasui; Bengt Winblad
Journal:  Lancet Neurol       Date:  2017-07-11       Impact factor: 44.182

3.  Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.

Authors:  Federico Massa; Lucia Farotti; Paolo Eusebi; Elisabetta Capello; Massimo E Dottorini; Cristina Tranfaglia; Matteo Bauckneht; Silvia Morbelli; Flavio Nobili; Lucilla Parnetti
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease.

Authors:  Matteo Cotta Ramusino; Valentina Garibotto; Ruggero Bacchin; Daniele Altomare; Alessandra Dodich; Frederic Assal; Aline Mendes; Alfredo Costa; Michele Tinazzi; Silvia D Morbelli; Matteo Bauckneht; Agnese Picco; Massimo E Dottorini; Cristina Tranfaglia; Lucia Farotti; Nicola Salvadori; Davide Moretti; Giordano Savelli; Anna Tarallo; Flavio Nobili; Maura Parapini; Carlo Cavaliere; Elena Salvatore; Marco Salvatore; Marina Boccardi; Giovanni B Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

5.  AMYPAD Diagnostic and Patient Management Study: Rationale and design.

Authors:  Giovanni B Frisoni; Frederik Barkhof; Daniele Altomare; Johannes Berkhof; Marina Boccardi; Elisa Canzoneri; Lyduine Collij; Alexander Drzezga; Gill Farrar; Valentina Garibotto; Rossella Gismondi; Juan-Domingo Gispert; Frank Jessen; Miia Kivipelto; Isadora Lopes Alves; José Luis Molinuevo; Agneta Nordberg; Pierre Payoux; Craig Ritchie; Irina Savicheva; Philip Scheltens; Mark E Schmidt; Jonathan M Schott; Andrew Stephens; Bart van Berckel; Bruno Vellas; Zuzana Walker; Nicola Raffa
Journal:  Alzheimers Dement       Date:  2018-10-16       Impact factor: 21.566

6.  Integrated diagnostics: proceedings from the 9th biennial symposium of the International Society for Strategic Studies in Radiology.

Authors:  G P Krestin; P A Grenier; H Hricak; V P Jackson; P L Khong; J C Miller; A Muellner; M Schwaiger; J H Thrall
Journal:  Eur Radiol       Date:  2012-06-15       Impact factor: 5.315

7.  Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.

Authors:  Inge M W Verberk; Rosalinde E Slot; Sander C J Verfaillie; Hans Heijst; Niels D Prins; Bart N M van Berckel; Philip Scheltens; Charlotte E Teunissen; Wiesje M van der Flier
Journal:  Ann Neurol       Date:  2018-10-04       Impact factor: 10.422

8.  Integrating pathology and radiology disciplines: an emerging opportunity?

Authors:  James Sorace; Denise R Aberle; Dena Elimam; Silvana Lawvere; Ossama Tawfik; W Dean Wallace
Journal:  BMC Med       Date:  2012-09-05       Impact factor: 8.775

Review 9.  An overview of clinical decision support systems: benefits, risks, and strategies for success.

Authors:  Reed T Sutton; David Pincock; Daniel C Baumgart; Daniel C Sadowski; Richard N Fedorak; Karen I Kroeker
Journal:  NPJ Digit Med       Date:  2020-02-06
  9 in total
  1 in total

1.  The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.

Authors:  Valentina Garibotto; Nathalie L Albert; Henryk Barthel; Bart van Berckel; Ronald Boellaard; Matthias Brendel; Diego Cecchin; Ozgul Ekmekcioglu; Elsmarieke van de Giessen; Eric Guedj; Adriaan A Lammerstma; Franck Semah; Tatjana Traub-Weidinger; Donatienne Van Weehaeghe; Silvia Morbelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-17       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.